[Primary sclerosing cholangitis : Current diagnostics and treatment]. / Primär sklerosierende Cholangitis : Aktuelle Diagnostik und Therapie.
Internist (Berl)
; 59(6): 551-559, 2018 06.
Article
em De
| MEDLINE
| ID: mdl-29700559
ABSTRACT
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology. Characteristic features are multifocal strictures and dilatations of the bile ducts. In 60-80â¯% of cases the PSC is strongly associated with chronic inflammatory bowel disease, mostly in the form of pancolitis. The diagnosis is established based on detection of typical cholangiographic lesions of the bile ducts and exclusion of secondary causes of sclerosing cholangitis. There is no approved medical treatment, but in Germany ursodeoxycholic acid is frequently used. Clinically relevant stenoses can be successfully treated by interventional endoscopy. Patients with PSC suffer from a greatly increased risk of hepatobiliary malignancies, especially with respect to cholangiocarcinoma and colorectal cancer and therefore require regular surveillance and screening. Liver transplantation is currently the only curative treatment option.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias dos Ductos Biliares
/
Colangite Esclerosante
/
Colangiocarcinoma
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
De
Ano de publicação:
2018
Tipo de documento:
Article